Breaking News

HCPC Study Reveals Degradation Risk

Evaluates conventional packaging vs high barrier unit dose blisters

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The Healthcare Compliance Packaging Council has released the results of a study investigating the potential degradation of three widely prescribed prescription drugs when packaged in conventional formats. The study results reveal the effect daily exposure to oxygen and moisture can have on non-coated Simvastatin, Lisinopril and Metformin tablets during in home use of multi-dose containers or through permeation of low barrier blister film typically used in Long Term Care settings.   The results i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters